Search Results - "Tsai, F"

Refine Results
  1. 1

    HLA‐Cw6 and psoriasis by Chen, L., Tsai, T.‐F.

    Published in British journal of dermatology (1951) (01-04-2018)
    “…Summary Psoriasis is a multifactorial disease with a strong genetic background. HLA‐Cw6 is one of the most strongly associated psoriasis susceptibility…”
    Get full text
    Journal Article
  2. 2

    Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double‐blind, phase III NAVIGATE trial by Langley, R.G., Tsai, T.‐F., Flavin, S., Song, M., Randazzo, B., Wasfi, Y., Jiang, J., Li, S., Puig, L.

    Published in British journal of dermatology (1951) (01-01-2018)
    “…Summary Background Guselkumab, an anti‐interleukin‐23 monoclonal antibody, has demonstrated significant efficacy in phase III psoriasis trials. Objectives To…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Secukinumab 2‐weekly vs. 4‐weekly dosing in plaque‐type psoriasis by Tsai, T.‐F.

    Published in British journal of dermatology (1951) (01-05-2021)
    “…Linked Article: Reich et al. Br J Dermatol 2021; 184:849–856…”
    Get full text
    Journal Article
  5. 5

    Secukinumab in patients with psoriasis who have responded inadequately to tumour necrosis factor inhibitor treatment by Tsai, T.‐F.

    Published in British journal of dermatology (1951) (01-07-2020)
    “…Linked Article: Warren et al. Br J Dermatol 2020; 183:60–70…”
    Get full text
    Journal Article
  6. 6

    Tofacitinib in patients with moderate‐to‐severe chronic plaque psoriasis: long‐term safety and efficacy in an open‐label extension study by Valenzuela, F., Korman, N.J., Bissonnette, R., Bakos, N., Tsai, T.‐F., Harper, M.K., Ports, W.C., Tan, H., Tallman, A., Valdez, H., Gardner, A.C.

    Published in British journal of dermatology (1951) (01-10-2018)
    “…Summary Background Tofacitinib is an oral Janus kinase inhibitor. Final safety and efficacy data from an open‐label extension study of tofacitinib in psoriasis…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    The safety profile of ustekinumab in the treatment of patients with psoriasis and concurrent hepatitis B or C by Chiu, H.-Y., Chen, C.-H., Wu, M.-S., Cheng, Y.-P., Tsai, T.-F.

    Published in British journal of dermatology (1951) (01-12-2013)
    “…Summary Background Ustekinumab, an interleukin (IL)‐12 and IL‐23 blocker, has emerged as a new therapeutic option for patients with psoriasis. It is generally…”
    Get full text
    Journal Article
  10. 10

    Human leucocyte antigen-Cw6 as a predictor for clinical response to ustekinumab, an interleukin-12/23 blocker, in Chinese patients with psoriasis: a retrospective analysis by Chiu, H.-Y., Wang, T.-S., Chan, C.-C., Cheng, Y.-P., Lin, S.-J., Tsai, T.-F.

    Published in British journal of dermatology (1951) (01-11-2014)
    “…Summary Background Ustekinumab, an interleukin‐12/23 inhibitor, is effective in the treatment of psoriasis. A recent Italian study showed more favourable…”
    Get full text
    Journal Article
  11. 11

    Older Adults’ Knowledge of Geriatric Depression and Its Related Factors by Y-F, Tsai, S-H, Lee

    Published in European psychiatry (01-08-2024)
    “…IntroductionEven though depression is a severe health issue among older adults, few studies have explored their knowledge of geriatric…”
    Get full text
    Journal Article
  12. 12

    Effects of a transition care program on depression, self-efficacy, and self-care behaviors in heart failure patients by H-S Yeh, Y-F, Tsai

    Published in European psychiatry (01-08-2024)
    “…IntroductionHeart failure is a progressive and unpredictable heart disease. How to work with these patients to decrease their psychological distress and…”
    Get full text
    Journal Article
  13. 13

    The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection by Tsai, T.-F., Ho, V., Song, M., Szapary, P., Kato, T., Wasfi, Y., Li, S., Shen, Y.K., Leonardi, C.

    Published in British journal of dermatology (1951) (01-11-2012)
    “…Summary Background  Ustekinumab is a monoclonal antibody that targets interleukin (IL)‐12/23 p40 to treat psoriasis. The IL‐12 pathway is also important in…”
    Get full text
    Journal Article
  14. 14

    Co-aggregation of major psychiatric disorders in individuals with first-degree relatives with schizophrenia: a nationwide population-based study by Cheng, C-M, Chang, W-H, Chen, M-H, Tsai, C-F, Su, T-P, Li, C-T, Tsai, S-J, Hsu, J-W, Huang, K-L, Lin, W-C, Chen, T-J, Bai, Y-M

    Published in Molecular psychiatry (01-08-2018)
    “…A previous genetic study has suggested that schizophrenia, bipolar disorder, major depressive disorder, autism spectrum disorder (ASD) and attention deficit…”
    Get full text
    Journal Article
  15. 15

    The role of β‐blockers in dermatological treatment: a review by Chen, L., Tsai, T.‐F.

    “…Many systemic medications have been used off‐label in cutaneous diseases. Use of β‐adrenergic‐blocking agents has risen in popularity among dermatologists…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Estimated global incidence of Japanese encephalitis: a systematic review by Campbell, Grant L, Hills, Susan L, Fischer, Marc, Jacobson, Julie A, Hoke, Charles H, Hombach, Joachim M, Marfin, Anthony A, Solomon, Tom, Tsai, Theodore F, Tsu, Vivien D, Ginsburg, Amy S

    Published in Bulletin of the World Health Organization (01-10-2011)
    “…To update the estimated global incidence of Japanese encephalitis (JE) using recent data for the purpose of guiding prevention and control efforts. Thirty-two…”
    Get full text
    Journal Article
  18. 18

    Increased risk of glomerulonephritis and chronic kidney disease in relation to the severity of psoriasis, concomitant medication, and comorbidity: a nationwide population-based cohort study by Chiu, H.-Y., Huang, H.-L., Li, C.-H., Yin, Y.-J., Chen, H.-A., Hsu, S.-T., Lin, S.-J., Tsai, T.-F., Ho, S.-Y.

    Published in British journal of dermatology (1951) (01-07-2015)
    “…Summary Background Few studies have examined the association between psoriasis and glomerulonephritis (GN) as well as chronic kidney disease (CKD). Objectives…”
    Get full text
    Journal Article
  19. 19

    Induction of ferroelectricity in nanoscale ZrO2/HfO2 bilayer thin films on Pt/Ti/SiO2/Si substrates by Lu, Y.W., Shieh, J., Tsai, F.Y.

    Published in Acta materialia (15-08-2016)
    “…Large ferroelectricity has been demonstrated in nanoscale bilayer thin films consisting of undoped ZrO2 and HfO2 layers on conventional Pt/Ti/SiO2/Si…”
    Get full text
    Journal Article
  20. 20

    Advanced Age and Increased Risk for Severe Outcomes of Dengue Infection, Taiwan, 2014-2015 by Huang, Nicole, Shen, Yi Jung, Chou, Yiing Jenq, Tsai, Theodore F, Lien, Chia En

    Published in Emerging infectious diseases (01-08-2023)
    “…Dengue, a mosquitoborne flavivirus infection, is increasingly a disease of older adults who are more likely to have chronic diseases that confer risk for…”
    Get full text
    Journal Article